Search by Drug Name or NDC

    NDC 00002-7715-63 BASAGLAR 100 [iU]/mL Details

    BASAGLAR 100 [iU]/mL

    BASAGLAR is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is INSULIN GLARGINE.

    Product Information

    NDC 00002-7715
    Product ID 0002-7715_dbb5654d-96c0-4cce-adba-5ae8c36acf80
    Associated GPIs 2710400300D220
    GCN Sequence Number 062867
    GCN Sequence Number Description insulin glargine,hum.rec.anlog INSULN PEN 100/ML (3) SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 98637
    HICL Sequence Number 022025
    HICL Sequence Number Description INSULIN GLARGINE,HUMAN RECOMBINANT ANALOG
    Brand/Generic Brand
    Proprietary Name BASAGLAR
    Proprietary Name Suffix KwikPen
    Non-Proprietary Name Insulin glargine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN GLARGINE
    Labeler Name Eli Lilly and Company
    Pharmaceutical Class Insulin Analog [EPC], Insulin [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA205692
    Listing Certified Through 2024-12-31

    Package

    NDC 00002-7715-63 (00002771563)

    NDC Package Code 0002-7715-63
    Billing NDC 00002771563
    Package 1 SYRINGE in 1 CARTON (0002-7715-63) / 3 mL in 1 SYRINGE
    Marketing Start Date 2016-07-15
    NDC Exclude Flag N
    Pricing Information N/A